These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20308820)

  • 21. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.
    Kocabas S; Yedicocuklu D; Askar FZ
    Eur J Anaesthesiol; 2008 Nov; 25(11):940-6. PubMed ID: 18538050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacodynamic effects of rocuronium during general anesthesia in patients with type 2 diabetes mellitus.
    Alper I; Ulukaya S; Makay O; Balcioglu T
    Minerva Anestesiol; 2010 Feb; 76(2):115-9. PubMed ID: 20150852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
    Sparr HJ; Khuenl-Brady KS; Eriksson LI
    Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of rocuronium (ORG 9426) and phenytoin in a patient undergoing cadaver renal transplantation: a possible pharmacokinetic mechanism?
    Szenohradszky J; Caldwell JE; Sharma ML; Gruenke LD; Miller RD
    Anesthesiology; 1994 May; 80(5):1167-70. PubMed ID: 8017655
    [No Abstract]   [Full Text] [Related]  

  • 27. Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone.
    Driessen JJ; Robertson EN; Booij LH; Vree TB
    Br J Anaesth; 1998 Mar; 80(3):386-8. PubMed ID: 9623443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of phenytoin on rocuronium-induced neuromuscular block in the rat phrenic nerve-hemidiaphragm preparation.
    Kim JU; Lee YK; Lee YM; Yang HO; Han SM; Yang HS
    J Neurosurg Anesthesiol; 2005 Jul; 17(3):149-52. PubMed ID: 16037736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of intramuscular rocuronium in infants and children.
    Reynolds LM; Lau M; Brown R; Luks A; Sharma M; Fisher DM
    Anesthesiology; 1997 Nov; 87(5):1096-105. PubMed ID: 9366462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation.
    Szenohradszky J; Fisher DM; Segredo V; Caldwell JE; Bragg P; Sharma ML; Gruenke LD; Miller RD
    Anesthesiology; 1992 Nov; 77(5):899-904. PubMed ID: 1443743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of rocuronium during the three stages of liver transplantation.
    Fisher DM; Ramsay MA; Hein HA; Marcel RJ; Sharma M; Ramsay KJ; Miller RD
    Anesthesiology; 1997 Jun; 86(6):1306-16. PubMed ID: 9197300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of rocuronium in children aged 4-11 years.
    Vuksanaj D; Fisher DM
    Anesthesiology; 1995 May; 82(5):1104-10. PubMed ID: 7741284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary, biliary and faecal excretion of rocuronium in humans.
    Proost JH; Eriksson LI; Mirakhur RK; Roest G; Wierda JM
    Br J Anaesth; 2000 Nov; 85(5):717-23. PubMed ID: 11094587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle distribution of the neuromuscular blocker gallamine using microdialysis.
    Sasongko L; Ramzan I; Williams KM; McLachlan AJ
    J Pharm Sci; 2002 Mar; 91(3):769-75. PubMed ID: 11920762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacodynamic modeling without plasma concentrations of rocuronium in children.
    Velázquez-Armenta EY; Nava-Ocampo AA
    J Clin Pharmacol; 2002 Jan; 42(1):37-42. PubMed ID: 11808822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries.
    Costa ACC; Coelho EB; Lanchote VL; Correia BV; Abumansur JT; Lauretti GR; de Moraes NV
    Eur J Clin Pharmacol; 2017 Aug; 73(8):957-963. PubMed ID: 28409297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromuscular paralysis as a pharmacodynamic probe to assess organ function during liver transplantation.
    Gao L; Ramzan I; Baker B
    J Clin Anesth; 2000 Dec; 12(8):615-20. PubMed ID: 11173001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rocuronium plasma concentrations during three phases of liver transplantation: relationship with early postoperative graft liver function.
    Gao L; Ramzan I; Baker B
    Br J Anaesth; 2002 Jun; 88(6):764-70. PubMed ID: 12173191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates.
    Kleef UW; Proost JH; Roggeveld J; Wierda JM
    J Chromatogr; 1993 Nov; 621(1):65-76. PubMed ID: 8308088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients.
    Weiss M; Reekers M; Vuyk J; Boer F
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):165-78. PubMed ID: 21125318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.